A planned merger between medical device coating manufacturers Surmodics and Biocoat is facing an antitrust lawsuit from the US Federal Trade Commission. The FTC believes the move would create an illegal monopoly. The US Federal Trade Commission (FTC) is challenging a planned merger of two large manufacturers of medical device coatings because, the commission says, it would be anticompetitive. More from Medtech Insight More from Geography